ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Health Petitions and Advocacy
Petitions, Press Releases and Position Statements
Meeting of the Pharmacy Compounding Advisory Committee Meeting Announcement
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 223896" data-attributes="member: 13851"><p>[URL unfurl="true"]https://www.fda.gov/advisory-committees/advisory-committee-calendar/june-8-2022-meeting-pharmacy-compounding-advisory-committee-meeting-announcement-06082022[/URL]</p><p></p><p></p><p><strong>Agenda</strong></p><p></p><p><em>The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform. <strong>The committee will discuss the following four bulk drug substances nominated for inclusion on the 503A Bulks List:</strong> Ammonium tetrathiomolybdate,<strong> enclomiphene citrate</strong>, ferric subsulfate, and glutathione. The chart below identifies the use(s) FDA reviewed for each of the four bulk drug substances being discussed at this advisory committee meeting. <strong>The nominators of these substances or another interested party will be invited to make a short presentation supporting the nomination.</strong></em></p><p><em><strong></strong></em></p><p><em><strong>[ATTACH=full]21802[/ATTACH]</strong></em></p></blockquote><p></p>
[QUOTE="madman, post: 223896, member: 13851"] [URL unfurl="true"]https://www.fda.gov/advisory-committees/advisory-committee-calendar/june-8-2022-meeting-pharmacy-compounding-advisory-committee-meeting-announcement-06082022[/URL] [B]Agenda[/B] [I]The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform. [B]The committee will discuss the following four bulk drug substances nominated for inclusion on the 503A Bulks List:[/B] Ammonium tetrathiomolybdate,[B] enclomiphene citrate[/B], ferric subsulfate, and glutathione. The chart below identifies the use(s) FDA reviewed for each of the four bulk drug substances being discussed at this advisory committee meeting. [B]The nominators of these substances or another interested party will be invited to make a short presentation supporting the nomination. [ATTACH type="full" alt="Screenshot (13087).png"]21802[/ATTACH][/B][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Health Petitions and Advocacy
Petitions, Press Releases and Position Statements
Meeting of the Pharmacy Compounding Advisory Committee Meeting Announcement
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top